Endoprosthesis Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to endoprosthesis market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Endoprosthesis Market News

in Endoprosthesis Market
  • In January 2025, W. L. Gore & Associates, a leading multinational American manufacturing organization announced the launch of Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis in Canada. The new endoprosthesis also features an Active Control system and is used for the treatment of AAA patients with aortic landing zones as short as 10 mm.
  • In December 2024, Merit Medical Systems Inc., a renowned manufacturer of disposable medical devices announced that it had received premarket approval from the US Food and Drug Administration (FDA) for its WRAPSODY Cell-Impermeable Endoprosthesis. The company can now focus on commercialization of its new endoprosthesis offering for the United States market.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Endoprosthesis Market size was valued at USD 10.16 Billion in 2023 and is poised to grow from USD 11.4 Billion in 2024 to USD 26.08 Billion by 2032, growing at a CAGR of 10.9% during the forecast period (2025-2032).

Endoprosthesis companies should focus on utilizing advanced manufacturing technologies such as 3D printing to make offerings more accessible. Investing in the R&D of custom and personalized endoprostheses is also a key opportunity for companies as per this global endoprosthesis market analysis. 'W. L. Gore & Associates', 'Merit Medical Systems Inc.', 'Stryker (US)', 'Johnson & Johnson Services, Inc. (US)', 'Corin Ltd (UK)', 'Medacta International SA (Switzerland)', 'Exactech, inc. (US)', 'MicroPort Orthopedics Inc. (US)', 'Smith & Nephew (UK)', 'Baumer S.A. (Switzerland)', 'Zimmer Biomet Holdings Inc. (US)', 'B. Braun Melsungen AG (Germany)'

Material innovations such as highly cross-linked polyethylene, titanium alloys, and ceramic composites have significantly enhanced the safety, longevity, and biocompatibility of endoprosthetic implants. These advanced materials reduce wear and tear, improve integration with bone, and minimize the risk of immune rejection or implant loosening. Hence, rising investments in biomaterials and coatings R&D is expected to favor the global endoprosthesis market outlook along with high preference for patient-specific endoprostheses.

Smart and Sensor-Integrated Implants: Smart implants embedded with biosensors to monitor implant performance in real-time are expected to be highly sought-after going forward. These implants can track parameters like load distribution, temperature, pressure, and early signs of infection or implant loosening. Data from such devices can be transmitted to physicians for proactive intervention, improving outcomes and extending implant life. As remote monitoring and AI analytics evolve, this endoprosthesis industry trend is slated to offer new opportunities for market players.

What Allows Endoprosthesis Sales to be Highest in North America?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Endoprosthesis Market
Endoprosthesis Market

Report ID: SQMIG35A3032

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE